Prestige Consumer Healthcare (PBH) EBITDA Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted EBITDA Margin of 29.1% for Q4 2025, little changed on a QoQ basis from 29.06% in Q3 2025, and down 257.0% year-over-year from 18.54% in Q4 2024.
Powered by 
Analysis
Prestige Consumer Healthcare (PBH) EBITDA Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare has reported EBITDA Margin for 16 years, with the latest figure at 29.1% in Q4 2025.
- On a quarterly basis, EBITDA Margin fell 257.0% year-over-year to 29.1% in Q4 2025; TTM through Dec 2025 was 29.21%, a 35.0% decrease from a year earlier, with the FY2025 full-year figure at 30.45%, down 70.0% from the prior year.
- EBITDA Margin was 29.1% for Q4 2025 at Prestige Consumer Healthcare, roughly flat from 29.06% in the prior quarter.
- The five-year high for EBITDA Margin was 33.93% in Q2 2021, with the low at 98.3% in Q1 2023.
- Average EBITDA Margin over 5 years is 23.6%, with a median of 29.77% recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: EBITDA Margin plunged 12730 bps in 2023, then surged 12795 bps in 2024.
- Over 5 years, EBITDA Margin stood at 30.09% in 2021, then grew by 5 bps to 31.64% in 2022, then retreated by 3 bps to 30.71% in 2023, then advanced by 3 bps to 31.68% in 2024, then dropped by 8 bps to 29.1% in 2025.
- The last three EBITDA Margin figures came in at 29.1% (Q4 2025), 29.06% (Q3 2025), and 28.76% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 18.95% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 17.67% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 15.11% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 14.27% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 2.30% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 9.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 4.39% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 11.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10% |
| Sep 30, 2025 | 29.06% |
| Jun 30, 2025 | 28.76% |
| Mar 31, 2025 | 29.82% |
| Dec 31, 2024 | 31.68% |
| Sep 30, 2024 | 29.72% |
| Jun 30, 2024 | 26.97% |
| Mar 31, 2024 | 29.66% |
| Dec 31, 2023 | 30.71% |
| Sep 30, 2023 | 30.82% |
| Jun 30, 2023 | 30.50% |
| Mar 31, 2023 | -98.30% |
| Dec 31, 2022 | 31.64% |
| Sep 30, 2022 | 29.17% |
| Jun 30, 2022 | 31.41% |
| Mar 31, 2022 | 29.01% |
| Dec 31, 2021 | 30.09% |
| Sep 30, 2021 | 28.44% |
| Jun 30, 2021 | 33.93% |
| Mar 31, 2021 | 29.84% |